This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Multisystem proteinopathy (MSP) is an inherited pleiotropic degenerative disorder that can affect muscle, bone, and the nervous system and was first reported as familial motor neuron disease in association with Paget disease of bone (PDB).1 The MSP phenotype also involves inclusion body myopathy (IBM) or frontotemporal dementia (FTD).2 The acronym “IBMPFD” describes some families with this syndrome, but it has outlived its usefulness since other phenotypic features sometimes dominate the clinical picture: parkinsonism3,4 and peripheral neuropathy5,6 occur, and motor neuron dysfunction is frequent (11 of 17 consecutive MSP cases in one series).7 An operational definition of MSP is a combination of 2 or more of IBM, PDB, and amyotrophic lateral sclerosis (ALS)/FTD (where ALS and FTD are considered as one spectrum). Histopathologically, MSP-affected tissues have ubiquitin-positive inclusions that contain RNA-binding proteins, such as TDP-43, hnRNPA1, and hnRNPA2B1, but may also include positive staining for proteins that mediate ubiquitin-dependent autophagy, including p62/SQSTM1, VCP, optineurin, and ubiquilin-2.8–10
Footnotes
Go to http://neurology.org/lookup/doi/10.1212/WNL.0000000000001862 for full disclosures. Funding information and disclosures deemed relevant by the author, if any, are provided at the end of the editorial.
See page 665
- © 2015 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Topics Discussed
Alert Me
Recommended articles
Motor neuron involvement in multisystem proteinopathy
SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles
Isolated inclusion body myopathy caused by a multisystem proteinopathy–linked hnRNPA1 mutation
SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis